Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 3228 | 47.5 |
09:34 ET | 1906 | 46.67 |
09:36 ET | 420 | 47.205 |
09:38 ET | 6125 | 46.9001 |
09:39 ET | 2325 | 47.34 |
09:41 ET | 1600 | 46.94 |
09:43 ET | 15780 | 46.99 |
09:45 ET | 723 | 47.06 |
09:48 ET | 2400 | 47.28 |
09:50 ET | 5571 | 47.285 |
09:52 ET | 300 | 47.36 |
09:54 ET | 1238 | 47.09 |
09:56 ET | 1500 | 47.03 |
09:57 ET | 3964 | 47.1 |
09:59 ET | 1052 | 47.05 |
10:01 ET | 800 | 47 |
10:03 ET | 1649 | 47.18 |
10:06 ET | 300 | 47.205 |
10:08 ET | 585 | 47.26 |
10:10 ET | 2347 | 47.365 |
10:12 ET | 700 | 47.25 |
10:14 ET | 100 | 47.255 |
10:15 ET | 1830 | 47.13 |
10:17 ET | 100 | 47.09 |
10:19 ET | 1437 | 47.11 |
10:21 ET | 320 | 47.27 |
10:24 ET | 400 | 47.19 |
10:26 ET | 600 | 47.12 |
10:28 ET | 927 | 47.15 |
10:30 ET | 423 | 47.19 |
10:32 ET | 133 | 47.21 |
10:33 ET | 7956 | 47.26 |
10:35 ET | 400 | 47.37 |
10:37 ET | 3232 | 47.58 |
10:39 ET | 1300 | 47.77 |
10:42 ET | 400 | 47.71 |
10:44 ET | 1435 | 47.58 |
10:46 ET | 800 | 47.6 |
10:48 ET | 648 | 47.635 |
10:50 ET | 400 | 47.62 |
10:51 ET | 200 | 47.57 |
10:53 ET | 650 | 47.4732 |
10:55 ET | 330 | 47.32 |
10:57 ET | 500 | 47.33 |
11:00 ET | 1300 | 47.19 |
11:02 ET | 200 | 47.26 |
11:06 ET | 100 | 47.205 |
11:08 ET | 200 | 47.13 |
11:11 ET | 100 | 47.165 |
11:13 ET | 2101 | 47.245 |
11:15 ET | 700 | 47.22 |
11:18 ET | 200 | 47.23 |
11:20 ET | 1710 | 47.025 |
11:22 ET | 1200 | 47 |
11:24 ET | 800 | 47.11 |
11:26 ET | 329 | 47.11 |
11:27 ET | 701 | 47.205 |
11:29 ET | 400 | 47.18 |
11:31 ET | 200 | 47.16 |
11:33 ET | 100 | 47.14 |
11:36 ET | 1959 | 47.16 |
11:38 ET | 300 | 47.19 |
11:40 ET | 600 | 47.16 |
11:42 ET | 1556 | 47.15 |
11:44 ET | 1230 | 47.13 |
11:45 ET | 998 | 47.07 |
11:47 ET | 3885 | 47.14 |
11:49 ET | 200 | 47.19 |
11:51 ET | 200 | 47.11 |
11:54 ET | 400 | 47.145 |
11:56 ET | 2268 | 47.04 |
11:58 ET | 100 | 47.02 |
12:00 ET | 2699 | 47.06 |
12:03 ET | 100 | 46.99 |
12:05 ET | 600 | 47 |
12:07 ET | 1069 | 47.04 |
12:09 ET | 520 | 47.1 |
12:12 ET | 400 | 47.03 |
12:14 ET | 1300 | 47.095 |
12:16 ET | 2741 | 47.18 |
12:18 ET | 300 | 47.205 |
12:20 ET | 1318 | 47.19 |
12:21 ET | 400 | 47.18 |
12:23 ET | 300 | 47.26 |
12:25 ET | 900 | 47.22 |
12:27 ET | 300 | 47.285 |
12:30 ET | 700 | 47.25 |
12:32 ET | 500 | 47.3 |
12:34 ET | 1100 | 47.25 |
12:36 ET | 1100 | 47.28 |
12:38 ET | 400 | 47.24 |
12:39 ET | 300 | 47.22 |
12:41 ET | 100 | 47.2 |
12:43 ET | 300 | 47.16 |
12:45 ET | 1162 | 47.14 |
12:48 ET | 450 | 47.1561 |
12:52 ET | 330 | 47.125 |
12:54 ET | 1200 | 47.135 |
12:56 ET | 1400 | 47.12 |
12:57 ET | 1329 | 47.185 |
12:59 ET | 200 | 47.19 |
01:01 ET | 800 | 47.19 |
01:03 ET | 500 | 47.15 |
01:06 ET | 1709 | 47.255 |
01:08 ET | 421 | 47.3 |
01:10 ET | 1200 | 47.31 |
01:12 ET | 700 | 47.28 |
01:14 ET | 600 | 47.3 |
01:15 ET | 422 | 47.295 |
01:17 ET | 100 | 47.25 |
01:19 ET | 300 | 47.26 |
01:21 ET | 760 | 47.31 |
01:24 ET | 100 | 47.33 |
01:26 ET | 100 | 47.335 |
01:28 ET | 1000 | 47.25 |
01:30 ET | 800 | 47.21 |
01:32 ET | 1000 | 47.14 |
01:33 ET | 500 | 47.16 |
01:35 ET | 500 | 47.18 |
01:37 ET | 300 | 47.04 |
01:39 ET | 100 | 47 |
01:42 ET | 900 | 46.98 |
01:44 ET | 1565 | 47.1 |
01:46 ET | 1100 | 47.14 |
01:48 ET | 1553 | 47.225 |
01:50 ET | 300 | 47.26 |
01:51 ET | 700 | 47.315 |
01:53 ET | 500 | 47.335 |
01:57 ET | 900 | 47.27 |
02:00 ET | 300 | 47.265 |
02:02 ET | 2100 | 47.245 |
02:04 ET | 500 | 47.245 |
02:06 ET | 1060 | 47.17 |
02:08 ET | 800 | 47.175 |
02:09 ET | 400 | 47.14 |
02:11 ET | 786 | 47.04 |
02:13 ET | 1200 | 47.09 |
02:15 ET | 100 | 47.14 |
02:18 ET | 2200 | 47.145 |
02:20 ET | 600 | 47.18 |
02:22 ET | 300 | 47.19 |
02:24 ET | 1422 | 47.28 |
02:26 ET | 300 | 47.34 |
02:27 ET | 1200 | 47.28 |
02:29 ET | 100 | 47.12 |
02:36 ET | 100 | 47.15 |
02:38 ET | 100 | 47.14 |
02:40 ET | 200 | 47.131 |
02:45 ET | 857 | 47.24 |
02:47 ET | 612 | 47.3 |
02:49 ET | 2278 | 47.3961 |
02:51 ET | 3355 | 47.39 |
02:54 ET | 1000 | 47.59 |
02:58 ET | 60245 | 47.64 |
03:00 ET | 300 | 47.53 |
03:02 ET | 1427 | 47.43 |
03:03 ET | 1116 | 47.38 |
03:05 ET | 1101 | 47.46 |
03:07 ET | 700 | 47.56 |
03:09 ET | 1000 | 47.5 |
03:12 ET | 200 | 47.525 |
03:14 ET | 300 | 47.49 |
03:16 ET | 618 | 47.545 |
03:18 ET | 1000 | 47.65 |
03:20 ET | 200 | 47.67 |
03:21 ET | 705 | 47.61 |
03:23 ET | 500 | 47.73 |
03:25 ET | 600 | 47.77 |
03:27 ET | 4600 | 47.75 |
03:30 ET | 1800 | 47.75 |
03:32 ET | 1164 | 47.755 |
03:34 ET | 900 | 47.73 |
03:36 ET | 1679 | 47.755 |
03:38 ET | 3167 | 47.715 |
03:39 ET | 100 | 47.71 |
03:41 ET | 200 | 47.71 |
03:43 ET | 400 | 47.73 |
03:45 ET | 7957 | 47.94 |
03:48 ET | 6770 | 47.9 |
03:50 ET | 2705 | 47.92 |
03:52 ET | 9783 | 47.845 |
03:54 ET | 8985 | 47.64 |
03:56 ET | 8306 | 47.64 |
03:57 ET | 9715 | 47.625 |
03:59 ET | 20472 | 47.61 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.5B | -7.6x | --- |
Avidity Biosciences Inc | 2.6B | -9.0x | --- |
Structure Therapeutics Inc | 2.5B | -22.9x | --- |
CG Oncology Inc | 2.4B | -31.0x | --- |
Intellia Therapeutics Inc | 2.3B | -4.2x | --- |
Iovance Biotherapeutics Inc | 2.3B | -4.3x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 84.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.